Brian Nowosielski

Exploring clinical prioritization and macroeconomic investment, researchers examine the link between disease and economic burden of diabetes.

With continued pressure for federal action regarding the abortion drug mifepristone, SCOTUS blocked a previous decision that would limit the pill’s access.

Despite WHO officials stating that risks from the outbreak remain low, experts are acting urgently to uncover details and provide support.

Kevin Day, PharmD, provides insight into his role in the Pharmacist Quality Rewards Program and what it’s doing for patients in his community.

Utilizing colleges and schools of pharmacy, researchers explorensolutions to the growing challenges affecting community pharmacy.

Among community pharmacies and their patients, researchers explore the power of protected learning time for improving services and outcomes.

With its capabilities improving rapidly in the health care space, technology and pharmacy experts discuss AI’s future place in pharmacy practice as further developments are released.

Amid shifting vaccine recommendations and an evolving health care landscape, pharmacists continue to weather the storm as frontline community immunizers.

An exploration of community pharmacists’ perceptions of e-pharmacy, assessing whether they believe it’s a threat or benefit.

In adult patients at least 50 years old, researchers estimated lifetime costs and health outcomes of the 23-valent pneumococcal polysaccharide vaccine.

In part 2 of our World Immunization Week interview with Nathan Ott, PharmD, he discusses the power of collaboration and continuing education in boosting vaccine awareness.

In this episode, host Taylor Watterson, PharmD, PhD, brings us a solo rendition breaking down some of her recent research with SCRPTS Laboratory.

The adeno-associated virus (AAV) vector-based gene therapy lunsotogene parvec-cwha received approval through the FDA Commissioner’s National Priority Voucher pilot program.

The drug’s indication for uncontrolled chronic spontaneous urticaria is the first biologic medicine of its kind, specifically explored amongst children 2 to 11 years old.

As the “peptide craze” fuels a surge in unregulated vendors, pharmacists must serve as critical navigators to steer patients toward safe, pharmaceutical-grade alternatives.

GSK’s investigational drug for liver treatment was given fast-track designations to improve access in what the FDA considers a significant unmet medical need.

Nathan Ott, PharmD, discusses the evolution of pharmacists’ role in vaccine administration and how that role has changed since the COVID-19 pandemic and prior.

Following an FDA announcement on its deeper look into peptide restrictions, Christopher Shade, PhD, joined to provide insights on their functions for metabolic health and more.

In a recent webinar sponsored by Drug Topics, pharmacy and insurance industry experts discuss the true impact of recent PBM reform efforts on the greater drug supply chain.

Pharmacists have the expertise to address acute and chronic pain distinctions, missed-dose protocols, tolerance and safety insights, and multimodal, non-pharmacological strategies for pain.

The FDA’s Pharmacy Compounding Advisory Committee will meet in late July of 2026 to convene on peptides and their inclusion on the 503A Bulk Drug Substances List.

In an evolving pharmacy landscape, accreditation can be difficult to manage, which is why experts like Mitch Lamb, PharmD, can steer businesses onto their desired paths.

This proposed rule builds on previous CMS guidance from 2020 and 2024.

New research examines what drives, or hinders, pharmacists when guiding patients through self-medication decisions for minor ailments like cold and flu.

In an exploration of pharmacists’ self-efficacy, researchers explored medication counseling outcomes for older adults across various languages.

Researchers conduct an exploration of e-prescription challenges and potential across pharmacies in Germany.

Sally Rafie, PharmD, BCPS, discusses current developments regarding access to the abortion pill and other notable events regarding women’s reproductive rights.

This episode highlights key DSCSA updates in 2026, T3 documentation going forward, and many more developments surrounding the law.

Low pneumococcal vaccine rates have potential to significantly impact a variety of at-risk populations, even groups of certain health care workers.

Researchers measure exactly how much pharmacist-provided care is being underbilled and what gaps mean for the future of reimbursement.